The Value Chain Shift: From IP Commercialization to Legacy Capital
Global Report·- The Hong Kong stock market is undergoing a structural divergence driven by core intellectual property, global supply chains, and platform effects. - Companies like Everest Medicines and Weichai Power achieved robust financial growth in 2026 by successfully commercializing products and expanding global networks. - Capital and traditional sectors are actively rebalancing their portfolios toward technology innovation while navigating ongoing asset cycles.Weichai Power drops 8% during session
HK Stock Market Update·From Power Grids to AI Data Centers: How Hong Kong Equities Are Pivoting in 2026
Global Report·- In the summer of 2026, Hong Kong-listed companies are actively driving strategic transformations amid shifting economic narratives. - Traditional and emerging sectors are evolving, with Weichai Power entering AI data center power equipment, ZTE launching a major computing center, and CLP Holdings reporting a net profit of 5.997 billion HKD. - Additional adjustments span from ASMPT's semiconductor rebound and Kintor Pharmaceutical's commercialization efforts to supply chain logistics operations.Weichai Power slides 3% in Hong Kong after sharp intraday drop
HK Stock Market Update·Weichai Power falls 8% on heavy trading amid corporate updates
HK Stock Market Update·Weichai Power falls 8% on Hong Kong trading as JPMorgan increases stake
HK Stock Market Update·